Clinical trials for kidney cancer
44 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
#NCT05118789
Locally Advanced
Metastatic
ROS-1
1
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Centre Hospitalier Universitaire de Nîmes (Nîmes), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 4 more...)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Breast cancer
Lung cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M1
Urothelial carcinoma
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes) (and 2 more...)
Constellation Pharmaceutique
Phase 1 / Phase 2
Kidney cancer
#NCT05706129
#2023-504254-35-00
Other
Localized
None
Systemic Treatment-Naive
Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Universitaire de Nantes (Nantes), IUCT Oncopôle (Toulouse), Hôpital de la Timone AP-HM (Marseille), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 3 more...)
Debiopharm International SA
Phase 1 / Phase 2
Kidney cancer
#NCT05706129
#2023-504254-35-00
Clear cell carcinoma
Locally Advanced
Metastatic
2
3 or more
Targeted therapy
Immunotherapy
Targeted therapy
Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Universitaire de Nantes (Nantes), IUCT Oncopôle (Toulouse), Hôpital de la Timone AP-HM (Marseille) (and 3 more...)
Debiopharm International SA
Phase 1 / Phase 2
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
#NCT05592626
#2023-505334-10-00
Locally Advanced
Metastatic
MSI/dMMR
1
2
3 or more
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Centre Léon Bérard (Lyon), IUCT Oncopôle (Toulouse), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux)
Marengo Therapeutics, Inc.
Phase 1 / Phase 2
#NCT04262466
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Institut Curie - Paris (Paris)
Immunocore Ltée
Phase 1
Centre Antoine Lacassagne (Nice)
Phase 1
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Phase 1
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)